Capital International Investors
KRTX

Capital International Investors’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Capital International Investors’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,227,102
Closed -$1.34B – 455
2023
Q4 		$1.34B Buy
4,227,102
+236,491
+6% +$46M 0.3% 89
2023
Q3 		$675M Sell
3,990,611
-1,938
-0% -$364K 0.17% 129
2023
Q2 		$866M Buy
3,992,549
+602,942
+18% +$129M 0.21% 121
2023
Q1 		$616M Buy
3,389,607
+1,694,028
+100% +$324M 0.16% 145
2022
Q4 		$333M Hold
1,695,579
– – 0.09% 197
2022
Q3 		$381M Buy
1,695,579
+664,845
+65% +$135M 0.11% 176
2022
Q2 		$130M Buy
1,030,734
+927,859
+902% +$107M 0.04% 274
2022
Q1 		$13M Buy
102,875
+24,275
+31% +$2.73M ﹤0.01% 417
2021
Q4 		$10.3M Hold
78,600
– – ﹤0.01% 424
2021
Q3 		$9.62M Hold
78,600
– – ﹤0.01% 424
2021
Q2 		$8.96M Sell
78,600
-295,600
-79% -$34.6M ﹤0.01% 431
2021
Q1 		$45M Hold
374,200
– – 0.01% 343
2020
Q4 		$38M Sell
374,200
-91,300
-20% -$8.46M 0.01% 351
2020
Q3 		$36M Sell
465,500
-9,100
-2% -$775K 0.01% 334
2020
Q2 		$52.9M Hold
474,600
– – 0.02% 302
2020
Q1 		$34.2M Buy
+474,600
New +$40.6M 0.01% 289

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Capital International Investors's KRTX Position: Q1 2024 in Review

Capital International Investors sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 4,227,102 shares — an estimated $1.34B sold.

Capital International Investors first reported a position in KRTX in Q1 2020 and held it in 16 quarters. The position peaked at $1.34B in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Capital International Investors reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Capital International Investors sold 4,227,102 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.34B.
  • Capital International Investors first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and held it in 16 quarters.
  • Capital International Investors's Karuna Therapeutics, Inc. Common Stock position peaked at $1.34B in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Capital International Investors's 13F filing for Q1 2024, filed 14 May 2024.